Nikolaos Triaridis INTERNIST

Medical Association of Athens

From May 2021: Consultant, 1^st Department of Internal Medicine “Hygeia”

2017-2021: Consultant,  4^th Department of Internal Medicine “Henry Dunant Hospital Center”

2014-2017: Consultant, Internal Medicine Department, Iaso General

2013-2014: Consultant, Internal Medicine Department, “Mitera”, Hygeia Group.

2011-2012: Consultant, 2^nd Department of Internal Medicine, General Hospital G.Gennimatas, Athens

2010-2011:Consultant, Internal Medicine Department, General Hospital of Nea Ionia “Agia Olga – Konstantinopouleio”-“General Patision Hospital”, Athens

2009-2010:Senior House Officer, 2^nd Department of Internal Medicine, General Hospital “Sismanogleion”, Athens

2008-2009: Consultant, Internal Medicine Department, General Hospital of Theva,Greece

2002-2007: Resident doctor in Internal Medicine in General Hospital “Evagelismos”, Athens, (2002-2003) and in General University Hospital “Attikon”,Athens (2002-2007).

1999-2001: Rural Medical Service at Fourfoura Medical Office and Health Center of Agia Foteini, Rethymnon  Prefecture, Crete, Greece

 Educational experience

Medical School, University of Ioannina, Greece.Graduation certificate: 1998

Specialty: 2^nd Propaedeutic Department of Internal Medicine, University of Athens, General Hospital “Evagelismos”, 2002 – 2003, and General Hospital “Attikon”, 2003 – 2007.

Title of Specialty :2007

 Post graduation education:

1. Evidence based medicine, clinical applications, 3^rd educational series, Athens.
2. Postgraduate Seminars with title: “Hypertension, New Guidelines”, Athens
3. Annual Panhellenic Educational Program in Infectious Diseases with Subject:”Guidelines”.Greek Association of Infectious Diseases.Athens.
4. 16^th Annual Postgraduate Program on Prehospital emergency Care (National Center of Emergeny Medical Help), Athens
5. Attendance and contribution to educational activities of Alfa Institute of Biomedical Siences (AIBS),Athens, Greece from 2013
6. “Good Clinical Practice ” 6th course. NIDA Clinical Trials Network.
7. Attendance of a many Greek and International Conferences (with  presentation of medical announcements in several of them)

Clinical Interest

Overal the broad spectrum of Internal Medicine, with special interest on:

Personalized approach of complicated medical cases

Infectious diseases

Diabetes mellitus

Hyperlipidemia

Arterial hypertension

Research Interest:

Infectious diseases,

Diabetes Mellitus

1.Tygecycline for the treatment of patients with clostridium difficile infections.An update of clinical evidenceKechagias KS, Chorepsima S, Triarides N.A, Falagas ME.Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1053-1058.          Epub 2020 Jan 11.

2.Resistance to fosfomycin: Mechanisms, Frequency and Clinical Consequences.Falagas ME, Athanasaki F, Voulgaris GL, Triarides N.A, Vardakas KZ.Int J Antimicrob Agents. 2019 Jan;53 (1):22-28.Epub 2018 Sep 27.Review.

3.An update on adverse drug reactions related to β-lactam antibiotics.Epub 2018 Sep 27.Vardakas K.Z, Kalimeris GD, Triarides N.A, Falagas ME.Expert Opin Drug Saf. 2018 May;17(5):499-508. Epub 2018 Apr 18. Review

4.Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek Hospitals.Falagas ME et Al, Cefiderocol Study Group.J Antimicrob Chemother. 2017 1;72(6):1704-1708

5.Colistin loading dose: evaluation of the published pharmacokinetic and clinical data.Vardakas KZ, Rellos K, Triarides N.A, Falagas ME.  Int J Antimicrob Agents.2016 Nov;48

6.Susceptibility of contemporary isolates to fosfomycin: a systemic review of the literature.Vardakas KZ, Legakis NJ, Triarides N.A, Falagas ME.Int J Antimicrob Agents 2016 Apr;47 (4):269-85.

7.Tetracyclines for multidrug resistant Acinetobacter baumanii infections . Falagas ME, Vardakas KZ, Kapaskelis A, Triarides N.A, Roussos  NS.Int J Antimicrob Agents.2015 May; 45(5):455-60.

8.Effectiveness and safety of high dose tigecycline-containing regiments for the treatment of severe bacterial infections.Falagas ME, Vardakas KZ, Tsiveriotis KP,Triarides N.A, Tansarli GS.Int J Antimicrob Agents.2014, Jul;44 (1)1-7

9.D-dimers evaluation in hospitalized patients. Haritos D, Triarides N et Al.Medimont International proceedings.Reprinted from 19th International Congress of Thrombosis, Tel Aviv, 2006.

10.Contineous glucose measurement by Glucoday.Comparison with the reference method with Hexokinase.Dimitriades G, Karamoutzos A, Triarides N.et Al.Diab and Metab,  2003.